Advertisement
Advertisement
BAX
Baxter International Inc.
16.63
USDSponsored
-0.02
-0.10%
Apr 07, 16:00 UTC -4
Closed
After-Market
17.34
+0.71
+4.27%
BAX Earnings Reports
Positive Surprise Ratio
BAX beat 32 of 40 last estimates.
80%
Next Report
Date of Next Report
Apr 29, 2026
Estimate for Q1 26 (Revenue/ EPS)
$2.64B
/$0.32
Implied change from Q4 25 (Revenue/ EPS)
-11.08%
/-27.27%
Implied change from Q1 25 (Revenue/ EPS)
+0.74%
/-41.82%
Baxter International Inc. earnings per share and revenue
On Feb 12, 2026, BAX reported earnings of 0.44 USD per share (EPS) for Q4 25, missing the estimate of 0.54 USD, resulting in a -18.73% surprise. Revenue reached 2.97 billion, compared to an expected 2.85 billion, with a 4.28% difference. The market reacted with a -15.99% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 11 analysts forecast an EPS of 0.32 USD, with revenue projected to reach 2.64 billion USD, implying an decrease of -27.27% EPS, and decrease of -11.08% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Lumexa Imaging Holdings, Inc. Common Stock
Report Date
Mar 26, 2026 For Q4 25
Estimate
$0.07
Actual
-$0.20
Surprise
-374.35%
Omeros Corporation
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$0.58
Actual
$0.98
Surprise
+268.56%
Tilray Brands, Inc. Common Stock
Report Date
Apr 01, 2026 For Q3 26
Estimate
-$0.14
Actual
-$0.24
Surprise
-68.07%
Sanara MedTech Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
$0.11
Actual
$0.09
Surprise
-19.79%
SANUWAVE Health, Inc. Common Stock
Report Date
Mar 26, 2026 For Q4 25
Estimate
$0.17
Actual
$0.89
Surprise
+413.26%
Oramed Pharmaceuticals Inc.
Report Date
Mar 26, 2026 For Q4 25
Estimate
$0.00
Actual
$0.24
Surprise
0.00%
FitLife Brands, Inc. Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
$0.21
Actual
$0.16
Surprise
-25.22%
Rockwell Medical, Inc. (DE) Common Stock
Report Date
Mar 26, 2026 For Q4 25
Estimate
$0.02
Actual
-$0.01
Surprise
-149.02%
Cytosorbents Corp.
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.09
Surprise
-76.47%
Innovative Eyewear, Inc. Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.43
Actual
-$0.14
Surprise
+68.08%
FAQ
What were Baxter International Inc.'s earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Baxter International Inc. reported EPS of $0.44, missing estimates by -18.73%, and revenue of $2.97B, 4.28% above expectations.
How did the market react to Baxter International Inc.'s Q4 2025 earnings?
The stock price moved down -15.99%, changed from $22.27 before the earnings release to $18.71 the day after.
When is Baxter International Inc. expected to report next?
The next earning report is scheduled for Apr 29, 2026.
What are the forecasts for Baxter International Inc.'s next earnings report?
Based on 11
analysts, Baxter International Inc. is expected to report EPS of $0.32 and revenue of $2.64B for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement